eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

Nucletron

Please kindly fill this survey in:
Educational Activity section evaluation
Interview with Professor Janusz Skowronek
ABS 2015
1/2015
 
Share:
Share:
more
 
 
abstract:

Original paper
The incidence of fat necrosis in balloon-based breast brachytherapy

Nitesh N. Paryani, Laura Vallow, Wilza Magalhaes, Michael G. Heckman, Siyong Kim, Ashley Smith, Nancy N. Diehl, Sarah McLaughlin

J Contemp Brachytherapy 2015; 7, 1: 29-34
Purpose: To investigate the incidence of and potential risk factors for fat necrosis in high dose-rate (HDR) balloon- based breast brachytherapy (BBB).

Material and methods: Fifty-four patients were treated postoperatively with HDR-BBB between May 2007 and December 2010. Median age was 71 years (range: 50-88 years). Median tumor size was 1 cm (range: 0.1-2.7 cm). Forty-four had invasive histology; 43% were grade 1, 24% grade 2, and 15% grade 3. The median margin size was 0.7 cm (range: 0.1-1.5 cm).

Results: With a median follow-up of 2.9 years (range: 0.5-5.2 years), local control was 98% with one in-breast failure, and overall survival was 89%. Fifty percent of patients experienced fat necrosis. Seven patients were symptomatic, with the remainder detected by mammography alone. Two patients required surgical resection with pathology confirming fat necrosis; 1 required i.v. steroids. At 1, 3, and 5 years following treatment, estimated cumulative incidences of fat necrosis were 7.5%, 52.7%, and 60.6%. Breast laterality, location, tumor size, histology, margin size, balloon volume, skin distance, skin dose, and number of dwell positions were not significantly associated with fat necrosis on univariate analysis.

Conclusions: In this retrospective review of HDR-BBB, we found a 50% incidence of both asymptomatic and symptomatic fat necrosis. Only three patients, however, required intervention. None of the risk factors considered were significantly associated with fat necrosis. Further studies evaluating factors associated with fat necrosis for patients undergoing HDR-BBB are necessary to appropriately assess the risks associated with treatment.
keywords:

brachytherapy, breast cancer, high-dose rate, necrosis, survival, toxicity

 
Quick links
© 2017 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe